Literature DB >> 19321184

Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.

Mitsuhiro Nakamura1, Jason M Bodily, Melanie Beglin, Satoru Kyo, Masaki Inoue, Laimonis A Laimins.   

Abstract

Human papillomaviruses (HPV) are the causative agents of cervical cancer and have been shown to increase expression of pro-angiogenic factors from infected cells. Many angiogenic factors are regulated by hypoxia inducible factor 1alpha (HIF-1alpha). We investigated whether HPV31 affects the levels of HIF-1alpha under normal and hypoxic conditions. Our studies indicate that cells containing complete HPV31 genomes showed enhanced levels of HIF-1alpha upon treatment with the hypoxia mimic DFO, which resulted from protein stabilization and led to increased expression of some but not all HIF-1alpha target genes. Both HPV E6 and E7 were able independently to enhance induction of HIF-1alpha upon DFO treatment. Enhancement of HIF-1alpha stability was not restricted to high-risk HPV types, as HPV11, a low risk HPV type, mediated a similar effect. These findings shed light on mechanisms by which HPV contributes to angiogenesis both in benign cervical lesions and in cervical cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321184      PMCID: PMC2674135          DOI: 10.1016/j.virol.2009.02.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  58 in total

1.  Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.

Authors:  Regina Wilson; Frauke Fehrmann; Laimonis A Laimins
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose.

Authors:  Regina Wilson; Laimonis A Laimins
Journal:  Methods Mol Med       Date:  2005

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 4.  Negative and positive regulation of HIF-1: a complex network.

Authors:  Julia I Bárdos; Margaret Ashcroft
Journal:  Biochim Biophys Acta       Date:  2005-07-25

5.  Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice.

Authors:  K Smith-McCune; Y H Zhu; D Hanahan; J Arbeit
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

6.  Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways.

Authors:  Oliver Bischof; Karim Nacerddine; Anne Dejean
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 7.  In vitro systems for the study and propagation of human papillomaviruses.

Authors:  C Meyers; L A Laimins
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

8.  Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.

Authors:  J T Thomas; L A Laimins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.

Authors:  W G An; M Kanekal; M C Simon; E Maltepe; M V Blagosklonny; L M Neckers
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

10.  Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.

Authors:  M N Ruesch; L A Laimins
Journal:  Virology       Date:  1998-10-10       Impact factor: 3.616

View more
  55 in total

Review 1.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

Review 2.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

Review 3.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

4.  Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.

Authors:  Helen J Mackay; Lari Wenzel; Linda Mileshkin
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

Review 5.  Persistence of human papillomavirus infection: keys to malignant progression.

Authors:  Jason Bodily; Laimonis A Laimins
Journal:  Trends Microbiol       Date:  2010-11-01       Impact factor: 17.079

6.  Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins.

Authors:  Marta Melar-New; Laimonis A Laimins
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

7.  Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling.

Authors:  Mandi Wiley; Kristin R Sweeney; Denise A Chan; Kevin M Brown; Curtis McMurtrey; Eric W Howard; Amato J Giaccia; Ira J Blader
Journal:  J Biol Chem       Date:  2010-06-25       Impact factor: 5.157

Review 8.  Oncogenic viruses and tumor glucose metabolism: like kids in a candy store.

Authors:  Evan Noch; Kamel Khalili
Journal:  Mol Cancer Ther       Date:  2012-01       Impact factor: 6.261

9.  Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.

Authors:  Johan A den Boon; Dohun Pyeon; Sophia S Wang; Mark Horswill; Mark Schiffman; Mark Sherman; Rosemary E Zuna; Zhishi Wang; Stephen M Hewitt; Rachel Pearson; Meghan Schott; Lisa Chung; Qiuling He; Paul Lambert; Joan Walker; Michael A Newton; Nicolas Wentzensen; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

Review 10.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.